Skip to main content
Signal8

Moore Matthew Richard

SEC insider (Form 3/4/5 filer). CIK 0001840191. Chief Operating Officer at Ventyx Biosciences, Inc. (VTYX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in SAN DIEGO, CA.

Companies Moore Matthew Richard has filed insider reports for

  • Ventyx Biosciences, Inc. (VTYX): Officer, Chief Operating Officer
Moore Matthew Richard profile photo

Moore Matthew Richard

CIK: 0001840191

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ventyx Biosciences, Inc. logo
VTYX

Ventyx Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Ventyx Biosciences, Inc. logo
    VTYX

    Ventyx Biosciences, Inc.

    Mar 4, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    145K shares-
  • Ventyx Biosciences, Inc. logo
    VTYX

    Ventyx Biosciences, Inc.

    Mar 4, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    320K shares-
  • Ventyx Biosciences, Inc. logo
    VTYX

    Ventyx Biosciences, Inc.

    Jan 2, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    145K shares-

1-3 of 3